Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ALDOC antisense RNA 1 (ALDOC-AS1) is a long non-coding RNA (lncRNA) gene located antisense to the ALDOC locus on the human genome[4]. As an antisense lncRNA, it is transcribed from the DNA strand opposite to the coding sequence of the ALDOC gene, which encodes Aldolase C, a glycolytic enzyme. Antisense lncRNAs are known to participate in gene regulation by various mechanisms, including modulation of gene transcription, RNA processing, stability, or translation of their sense counterparts, but the specific regulatory role or biological significance of ALDOC-AS1 has not been established in published literature as of the current date. There is no evidence in major databases that it serves as a direct therapeutic or diagnostic target, is implicated in major diseases, or interacts with known drugs.
No drug mechanism of action known for ALDOC-AS1, as no drugs are known to target it. As a class, lncRNAs can influence chromatin structure, transcription, and post-transcriptional events, but details for ALDOC-AS1 are not available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ALDOC antisense RNA 1 (ALDOC-AS1).